Skip to main content

TC BioPharm (Holdings) plc

TCBPDelisted Aug 8, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001872812

TC BioPharm (Holdings) plc was delisted on Aug 8, 2025; its insiders filed their last Form 4 on Jan 11, 2023; 12 institutions reported holding it in 13F filings for Q3 2023, worth $179.6K in total; no superinvestor held it.

13F holders, Q2 2022

Institutional positions in TC BioPharm (Holdings) plc as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
5
−3 vs. Q1 2022
Shares held
451.4K
+172.3K (+61.7%) vs. Q1 2022
Total value
$166.0K
−$233.0K (−58.4%) vs. Q1 2022
New holders
4
1 more added
Sold out
7
0 more reduced

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TCBP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 5 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 8 institutionsQ2 2022: 5 institutionsQ3 2022: 5 institutionsQ4 2022: 2 institutionsQ1 2023: 4 institutionsQ2 2023: 6 institutionsQ3 2023: 12 institutionsQ4 2023: 4 institutionsQ1 2024: 5 institutionsQ2 2024: 8 institutionsQ3 2024: 8 institutionsQ4 2024: 12 institutionsQ1 2025: 1 institutionQ2 2025: 1 institutionQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2022: $166.0K
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $399.0KQ2 2022: $166.0KQ3 2022: $141.0KQ4 2022: $323.8KQ1 2023: $207.3KQ2 2023: $380.1KQ3 2023: $179.6KQ4 2023: $243.8KQ1 2024: $42.6KQ2 2024: $77.0KQ3 2024: $48.9KQ4 2024: $34.8KQ1 2025: $34Q2 2025: $34Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding TCBP and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20251$34
Q1 20251$34
Q4 202412$34.8K
Q3 20248$48.9K
Q2 20248$77.0K
Q1 20245$42.6K
Q4 20234$243.8K
Q3 202312$179.6K
Q2 20236$380.1K
Q1 20234$207.3K
Q4 20222$323.8K
Q3 20225$141.0K
Q2 20225$166.0K
Q1 20228$399.0K
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding TC BioPharm (Holdings) plc; share changes are against Q1 2022.

Institutions holding TCBP in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Legal & General Group Plc207,258$76.0K0.00%+207,258New
KCL Capital, L.P.100,000$37.0K0.02%+100,000New
Warberg Asset Management LLC99,165$36.0K0.01%+99,165New
Virtu Financial LLC23,466$9.00K0.00%+7,172+44.0%Added
Renaissance Technologies LLC21,475$8.00K0.00%+21,475New
Kepos Capital LP0$00.00%−184,757−100.0%Sold out
Citadel Advisors LLC0$00.00%−22,379−100.0%Sold out
Two Sigma Securities, LLC0$00.00%−20,859−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−17,305−100.0%Sold out
Jane Street Group, LLC0$00.00%−15,688−100.0%Sold out
UBS Group AG0$00.00%−1,191−100.0%Sold out
Citigroup Inc0$00.00%−600−100.0%Sold out